Sassi, Y;Abi-gerges, A;Ahles, A;Hatem, S;Hulot, JS;Lompre, AM;Engelhardt, S
The efflux protein MRP4 controls cAMP homeostasis in cardiac myocytes
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
71-71

Hofmann, F;Ludwig, A;Herrmann, S
Electrophysiological Characterization of I-f in Cardiac Hypertrophy
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
60-60

Gobel, P;Rochais, F;Zahedi, R;Sickmann, A;Engelhardt, S
Characterization of the cardiac beta-adrenergic phosphoproteome
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
56-56

Ahles, A;Rochais, F;Frambach, T;Bünemann, M;Engelhardt, S
A memory mechanism in the beta(2)-adrenergic receptor critical for downstream signaling and individual drug responses
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
51-52

Ramanujam, DP;Fauconnier, J;Sassi, Y;Merkle, S;Muhlstedt, S;Dupuis, M;Schmitt, JP;Braun, A;Nieswandt, B;Hulot, JS;Engelhardt, S
A critical role for STIM in cardiomyocyte hypertrophy in vitro and in vivo
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
48-48

Jentzsch, C;Braun, A;Frost, R;Florhschutz, I;Nieswandt, B;Engelhardt, S
Deletion of the cardiac secreted factor PI16 in mice
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
45-45

Hammelmann, V;Biel, M;Zong, X;Michalakis, S;Hofmann, F
The cGMP-dependent Protein Kinase II is an Inhibitory Modulator of the Hyperpolarization-activated HCN2 Channel
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
43-43

Jurik, A;Fischer, S;Thoringer, C;Wotjak, C;Moosmang, S
The IQ motif of the L-type channel Ca(v)1.2 plays a role in mood disorders
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
31-31

Brandmayr, J;Moosmang, S
Regulatory effects of the Ca-v beta(2) subunit on the Ca(v)1.2 channel complex
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
31-31

Desch, M;Schinner, E;Kees, F;Hofmann, F;Seifert, R;Schlossmann, J
Cyclic cytidine 3 ',5 '-monophosphate (cCMP) signals via cGMP kinase I
Naunyn Schmiedebergs Arch Pharmacol
2011
383 1
30-30